Biotech · Public company · Vienna, VA, US

Cel Sci Corp

Ticker CVM · SEC CIK 0000725363

Track this companyFree. Adds Cel Sci Corp to your Dealase workspace and tells you when its record changes.

Clinical trials20 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline7

CisplatinPhase 3 · Squamous Cell Carcinoma of the Oral CavityClinicalTrials.gov · fetched Nov 12, 2026
CyclophosphamidePhase 3 · Squamous Cell Carcinoma of the Oral CavityClinicalTrials.gov · fetched Nov 12, 2026
IndomethacinPhase 3 · Squamous Cell Carcinoma of the Oral CavityClinicalTrials.gov · fetched Nov 12, 2026
LIPhase 3 · Squamous Cell Carcinoma of the Oral CavityClinicalTrials.gov · fetched Nov 12, 2026
SurgeryPhase 3 · Squamous Cell Carcinoma of the Oral CavityClinicalTrials.gov · fetched Nov 12, 2026
ZincPhase 3 · Squamous Cell Carcinoma of the Oral CavityClinicalTrials.gov · fetched Nov 12, 2026
Leukocyte Interleukin, InjectionPhase 1 · Perianal WartsClinicalTrials.gov · fetched Nov 12, 2026

Study of Leukocyte Interleukin, Injection for Treatment of Perianal WartsPHASE1 · TERMINATED · started Apr 1, 2015ClinicalTrials.gov NCT03038828 · fetched Nov 12, 2026
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral CavityPHASE3 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01265849 · fetched Nov 12, 2026